GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

116 calculators match

Most used

21
MELD-NaAssesses the severity of chronic liver diseaseChild-Pugh ScoreAssesses the prognosis of chronic liver disease, mainly cirrhosisFIB-4 IndexLiver fibrosis scoring indexAPRIAST to platelet ratio — liver fibrosisMaddrey's DFAlcoholic hepatitis severityGlasgow-BlatchfordUpper GI bleed risk stratificationGAHSGlasgow alcoholic hepatitis scoreMontreal IBDIBD classification — CD & UCMayo ScoreUlcerative colitis activityBISAP ScoreBedside index for severity of pancreatitisCLIF-SOFAOrgan failure scoring in cirrhosisAlcohol ContentStandard drinks & alcohol grams calculatorAARC-ACLFAcute-on-chronic liver failure gradePELD / CR ScorePediatric end-stage liver diseaseHarvey-BradshawCrohn's disease activity indexCTSICT severity index — pancreatitisRockall ScoreGI bleed rebleeding & mortality riskCAGEAlcohol use disorder screening (4 questions)MELD 3.0Updated MELD — sex-inclusive formulaAUDIT ScoreAlcohol use disorders identification testVOCAL-Penn ScorePost-operative mortality risk in cirrhosis surgery

Liver & Cirrhosis

17
ALBI GradeAlbumin-bilirubin liver function grade in HCCUKELD ScoreUK model for end-stage liver diseaseMELD-XIMELD excluding INR — for anticoagulated patientsWest Haven CriteriaHepatic encephalopathy gradingMilan CriteriaLiver transplant eligibility in hepatocellular carcinomaLI-RADS v2018 (CT/MRI)Liver observation category from size, APHE and major featuresBCLC StagingHepatocellular carcinoma stage and treatment allocationSimplified AIH CriteriaSimplified criteria for autoimmune hepatitisRevised Original AIH ScoreIAIHG 1999 comprehensive autoimmune hepatitis scoreSAAGSerum-ascites albumin gradient — cause of ascitesR FactorHepatocellular vs cholestatic pattern in liver injuryCLIF-C ACLFMortality prediction in acute-on-chronic liver failureKing's College CriteriaTransplant criteria in acute liver failureGALAD ScoreHCC detection from gender, age, AFP-L3, AFP and DCPMetroticket 2.0AFP-adjusted up-to-seven for HCC transplant eligibilityRUCAMCausality in drug- and herb-induced liver injuryBaveno VII CriteriacACLD, CSPH and sparing screening endoscopy

Fibrosis & MASLD

8
NAFLD Fibrosis ScoreAdvanced fibrosis probability in MASLD/NAFLDBARD ScoreBMI, AST/ALT ratio, diabetes — MASLD fibrosisFatty Liver IndexPredicts hepatic steatosis from routine labsFibrotic NASH Index (FNI)At-risk NASH probability from AST, HbA1c and HDLNAFLD Activity Score (NAS)Histologic activity grade — steatosis, inflammation, ballooningMEFIB IndexMRE + FIB-4 rule for significant fibrosis (≥F2) in MASLDFAST ScoreFibroScan-AST — at-risk NASH from LSM, CAP and ASTSAFE ScoreSteatosis-Associated Fibrosis Estimator for MASLD in primary care

Pancreas & Biliary

8
Ranson's CriteriaAcute pancreatitis severity at 48 hoursGlasgow-Imrie CriteriaAcute pancreatitis severity — the PANCREAS criteriaHAPSHarmless acute pancreatitis scoreTokyo Guidelines — CholangitisTG18 diagnosis and severity grade for acute cholangitisTokyo Guidelines — CholecystitisTG18 diagnosis and severity grade for acute cholecystitisBiliary Pain (Rome IV)Rome IV — defining biliary-type pain before interventionFunctional Pancreatic SODRome IV — pancreatic sphincter of Oddi disorderRevised Atlanta ClassificationAcute pancreatitis severity — mild, moderately severe, severe

IBD

9
Truelove & Witts CriteriaAcute severe ulcerative colitis — admission decisionUCEISUlcerative colitis endoscopic index of severitySCCAISimple clinical colitis activity index — symptoms onlyCDAICrohn's disease activity index — the trial standardSES-CDEndoscopic severity in Crohn's diseasePUCAIPaediatric ulcerative colitis activity indexTravis (Oxford) CriteriaDay 3 colectomy risk in acute severe ulcerative colitisHo IndexDay 3 steroid failure risk in acute severe ulcerative colitisRutgeerts ScorePostoperative Crohn's recurrence at ileocolonoscopy

GI Bleeding

7
EVendo ScorePredicts oesophageal varices needing treatmentForrest ClassificationPeptic ulcer bleeding — rebleeding risk at endoscopyAIMS65 ScoreUpper GI bleed mortality — five bedside criteriaOakland ScoreSafe-discharge risk for acute lower GI bleedingABC ScoreAge, blood tests, comorbidities — GI bleed mortalitySarin ClassificationEndoscopic classification of gastric varicesEGUS (Gastric Ulcer)Malignancy risk in a gastric ulcer, and who needs repeat endoscopy

Alcohol

2
ABIC ScoreAge, bilirubin, INR, creatinine — alcoholic hepatitisLille ModelSteroid response at day 7 in alcoholic hepatitis

Upper GI

4
Chicago Classification v4.0Oesophageal motility pattern from high-resolution manometryLA Classification (Oesophagitis)Los Angeles grade A–D for erosive oesophagitisPrague C & M CriteriaCircumferential and maximal extent of Barrett's oesophagusEREFS (Eosinophilic Oesophagitis)Endoscopic reference score — oedema, rings, exudates, furrows, stricture

Colorectal

3
Boston Bowel Prep ScaleColonoscopy preparation adequacy by segmentStool Osmotic GapOsmotic vs secretory diarrhoea from stool electrolytesATLAS Score (C. difficile)Predicted response to therapy in Clostridioides difficile infection

Functional GI

37
Bristol Stool ScaleStool form types 1–7 and colonic transitRome IV Criteria for IBSIrritable bowel syndrome diagnosis and subtypeFunctional ConstipationRome IV — two of six items, IBS excludedOpioid-Induced ConstipationRome IV — constipation tied to opioid therapyFunctional DiarrhoeaRome IV — loose stools without predominant painFunctional Bloating / DistensionRome IV — bloating without other bowel disorder criteriaUnspecified Functional Bowel DisorderRome IV — bowel symptoms fitting no other categoryCentrally Mediated Abdominal Pain (CAPS)Rome IV — continuous pain unrelated to gut eventsNarcotic Bowel SyndromeRome IV — opioid-induced hyperalgesia of the gutFaecal Incontinence (Rome IV)Rome IV — the criteria, and why nobody is askedFunctional Anorectal PainLevator ani, unspecified pain and proctalgia fugaxFunctional Defecation DisordersRome IV — dyssynergia and inadequate propulsionInfant RegurgitationRome IV — the happy spitter, and the alarm features that rule it outInfant ColicRome IV — recurrent unexplained crying in a well infant under 5 monthsInfant DyscheziaRome IV — straining before a soft stool, and why not to intervenePaediatric Functional ConstipationRome IV — two of six over one month, with overflow soiling as a criterionToddler's DiarrhoeaRome IV functional diarrhoea of childhood — painless, thriving childPaediatric Cyclic Vomiting SyndromeRome IV — both age bands, with different criteria for eachPaediatric Rumination SyndromeRome IV — infant and child/adolescent criteriaFunctional Nausea & Vomiting (Children)Rome IV — two separate disorders that can be met togetherAerophagiaRome IV — distension that increases through the dayPaediatric Functional DyspepsiaRome IV — four times a month, with PDS and EPS subtypingPaediatric Irritable Bowel SyndromeRome IV — plus the constipation clause clinicians missAbdominal MigraineRome IV — stereotypical incapacitating episodes weeks apartFunctional Abdominal Pain — NOSRome IV — the residual category, reached after the other threeNonretentive Faecal IncontinenceRome IV — soiling without retention, where laxatives make it worseFunctional DyspepsiaRome IV — with PDS and EPS subtypingRumination SyndromeRome IV — effortless regurgitation without retchingCyclic Vomiting SyndromeRome IV — stereotypical episodic vomitingCannabinoid HyperemesisRome IV — CVS pattern relieved by cannabis cessationChronic Nausea & VomitingRome IV — chronic nausea and vomiting syndromeBelching DisordersRome IV — supragastric vs gastric belchingFunctional HeartburnRome IV — heartburn with normal acid exposureReflux HypersensitivityRome IV — normal acid exposure, positive symptom associationFunctional Chest PainRome IV — non-cardiac, non-reflux chest painGlobusRome IV — painless lump-in-throat sensationFunctional DysphagiaRome IV — dysphagia with normal endoscopy and manometry
  1. Calculators
  2. /
  3. EREFS (Eosinophilic Oesophagitis)
Upper GI

EREFS (Eosinophilic Oesophagitis)

Endoscopic reference score — oedema, rings, exudates, furrows, stricture

Inflammatory feature. Also described historically as mucosal pallor or decreased vascularity.

Fibrostenotic feature. Historically called concentric rings, corrugated oesophagus or trachealisation.

Inflammatory feature. Historically called white spots or plaques.

Inflammatory feature. The original system grades this 0–1; some later studies use 0–2, which changes the maximum total.

Fibrostenotic feature.

Score the worst-affected segment for each feature. The total matters less than its split: the inflammatory features respond to medical therapy, the fibrostenotic ones often do not, and a score made up entirely of rings and stricture means something quite different from the same number made of exudates and oedema.

When to use
Use it at every endoscopy in suspected or established eosinophilic oesophagitis — at diagnosis to establish a baseline, and at each follow-up to judge response. Its value is largely in serial use: the score was designed so that the change under treatment can be measured rather than described. Record it even when the oesophagus looks normal, because a documented zero is what makes a later score interpretable. It grades endoscopic appearance only and does not replace histology, which remains the diagnostic standard.
Why use it
Because endoscopic descriptions in eosinophilic oesophagitis were, until this system, both inconsistent and untethered from any scale. The same finding appeared in reports as trachealisation, corrugated oesophagus, concentric rings or feline oesophagus, and there was no way to say whether a patient had improved. EREFS supplied common nomenclature and a severity scale for five features, validated for interobserver agreement across 21 gastroenterologists reviewing videos of 25 patients. The subscore split is what makes it clinically useful rather than merely tidy: it separates the component that anti-inflammatory treatment can change from the component that generally requires dilation, which is precisely the question a follow-up endoscopy is being done to answer.
Formula, evidence and interpretation

About the Eosinophilic Oesophagitis Endoscopic Reference Score (EREFS)

Five features scored on the worst-affected segment: oedema 0–1, rings 0–3, exudates 0–2, furrows 0–1 and stricture 0–1, giving a maximum of 8. What matters more than the total is its composition. The inflammatory subscore — oedema plus exudates plus furrows, maximum 4 — is what responds to topical corticosteroids, proton pump inhibitors or dietary elimination. The fibrostenotic subscore — rings plus stricture, also maximum 4 — reflects established remodelling and often will not, so a score of 4 made entirely of rings and stricture means something quite different from a 4 made of exudates and oedema. A normal-looking oesophagus does not exclude the diagnosis, which is why biopsies are mandatory regardless.

On this page

  • Formula
  • Interpreting the result
  • Inputs
  • What it returns
  • How it is calculated
  • Facts & figures
  • Evidence
  • How it compares
  • Pearls & pitfalls
  • Critical actions
  • Why it exists
  • About the creator
  • Limitations
  • If you are the patient
  • FAQ
  • Related calculators
  • References

Formula

EREFS = oedema (0–1) + rings (0–3) + exudates (0–2) + furrows (0–1) + stricture (0–1) Inflammatory subscore = oedema + exudates + furrows (0–4) Fibrostenotic subscore = rings + stricture (0–4) Total maximum 8
Inflammatory features
Oedema, exudates and furrows. These respond to topical corticosteroids, proton pump inhibitors and dietary elimination.
Fibrostenotic features
Rings and stricture. These reflect remodelling and often require dilation rather than anti-inflammatory therapy alone.
  • Score the worst-affected segment for each feature, so that maximal disease burden is captured rather than averaged away.
  • The original system grades furrows 0–1, giving a maximum total of 8. Some later studies grade furrows 0–2, and some report proximal and distal segments separately for a total up to 20 — always state which convention a score was recorded under.
  • A score of zero does NOT exclude eosinophilic oesophagitis. A meaningful minority of patients with histologically confirmed disease have a normal-appearing oesophagus, which is why biopsies are mandatory whenever the diagnosis is considered.
  • The subscore split carries more information than the total. The same total of 4 means different things depending on whether it came from inflammatory or fibrostenotic features.
  • The rings grading is anchored to endoscope passage rather than to appearance alone, which is what makes grade 2 and 3 reproducible.

Interpreting the result

Read the two subscores before the total. An inflammatory-only pattern is the one most likely to respond to treatment, and the inflammatory subscore falling on a follow-up endoscopy is good evidence that therapy is working. A fibrostenotic-only pattern suggests established remodelling without much active inflammation, and is the pattern least likely to improve with medical therapy alone — here, dilation is often what changes a patient's dysphagia, and it is worth confirming histological activity before escalating anti-inflammatory treatment for a finding that will not respond to it. A mixed pattern needs both approaches, and importantly means residual dysphagia after successful anti-inflammatory treatment should not automatically be read as treatment failure: the inflammation may have resolved while the rings have not. A total of zero is not a negative test. Take biopsies anyway — at least six, from at least two levels — because endoscopic appearance and histology diverge often enough that relying on the former alone misses the diagnosis.

ScoreBandWhat it meansAction
Total 0No endoscopic featuresDoes not exclude eosinophilic oesophagitis — a meaningful minority of histologically confirmed cases have a normal-appearing oesophagusTake biopsies regardless; record the zero as a baseline
Inflammatory subscore > 0, fibrostenotic 0Inflammatory features onlyOedema, exudates or furrows without remodelling. The pattern most responsive to medical therapyTopical corticosteroids, proton pump inhibitor or dietary elimination; expect the inflammatory subscore to fall
Fibrostenotic subscore > 0, inflammatory 0Fibrostenotic features onlyRings or stricture without active inflammation. Least likely to improve with medical therapy aloneConsider dilation; confirm histological activity before escalating anti-inflammatory treatment
Both subscores > 0Mixed inflammatory and fibrostenoticActive inflammation on a background of established remodellingTreat the inflammation and reassess before attributing residual dysphagia to treatment failure; dilation may still be needed

What the EREFS (Eosinophilic Oesophagitis) needs (5 inputs)

Oedema (0–1)
0 absent, with distinct vascular markings visible; 1 present, with loss of vascular markings. An inflammatory feature, historically described as mucosal pallor or decreased vascularity.
Rings (0–3)
0 absent; 1 mild, subtle circumferential ridges; 2 moderate, distinct rings that a standard adult endoscope passes; 3 severe, distinct rings that it does not. A fibrostenotic feature, historically called concentric rings, corrugated oesophagus or trachealisation.
Exudates (0–2)
0 absent; 1 mild, involving under 10% of the surface area; 2 severe, involving over 10%. An inflammatory feature, historically called white spots or plaques.
Furrows (0–1)
0 absent, 1 present. An inflammatory feature, also called vertical lines or longitudinal furrows. The original system grades this 0–1; some later studies use 0–2, which changes the maximum total.
Stricture (0–1)
0 absent, 1 present. A fibrostenotic feature.

What it returns

Total EREFS
0 to 8, summing all five features scored on the worst-affected segment.
Inflammatory subscore (0–4)
Oedema plus exudates plus furrows. The component expected to fall with successful medical therapy, and the one worth tracking across endoscopies.
Fibrostenotic subscore (0–4)
Rings plus stricture. Reflects established remodelling and may persist despite adequate anti-inflammatory treatment.

How it is calculated

The system began as a nomenclature problem rather than a scoring one. Hirano and colleagues noted that the same endoscopic findings in eosinophilic oesophagitis were being reported under a proliferation of different names, which made it impossible to compare studies or to say whether an individual patient had improved. They defined five features in standardised terms, attached severity grades where a meaningful gradation existed, and then tested interobserver agreement by having 21 gastroenterologists score video recordings from 25 patients. Agreement was good for the four major features after modification, which is what the paper set out to establish. The grading choices reflect what can actually be judged consistently: rings are anchored to whether a standard adult endoscope passes rather than to subjective severity, exudates to a surface-area proportion, and oedema, furrows and stricture kept binary because intermediate grades did not reproduce.

Facts & figures

The five features and their grades
FeatureGroupGrades
OedemaInflammatory0 absent (vascularity visible) · 1 present (loss of vascular markings)
RingsFibrostenotic0 absent · 1 subtle ridges · 2 distinct, endoscope passes · 3 distinct, endoscope does not pass
ExudatesInflammatory0 absent · 1 under 10% of surface · 2 over 10%
FurrowsInflammatory0 absent · 1 present
StrictureFibrostenotic0 absent · 1 present

Inflammatory maximum 4, fibrostenotic maximum 4, total maximum 8. Rings are graded by whether a standard adult endoscope passes, which is what makes grades 2 and 3 reproducible.

Why the same total can mean different things
FindingsTotalInflammatoryFibrostenoticImplication
Oedema 1, exudates 2, furrows 1440Should respond to medical therapy
Rings 3, stricture 1404Established remodelling; consider dilation
Oedema 1, rings 3413Mixed — treat inflammation, expect residual rings

Three patients with an identical total of 4 face three different treatment decisions. This is the argument for recording both subscores rather than the total alone.

Evidence

Derivation and validation — Hirano et al.

2013 · n = 25

Endoscopic video recordings from 25 patients with eosinophilic oesophagitis, reviewed by 21 gastroenterologists to assess interobserver agreement on a proposed classification and grading system for the major oesophageal features.

After modification, the grading system demonstrated good agreement for the four major features of eosinophilic oesophagitis — rings, furrows, exudates and oedema — with moderate to good kappa values, establishing common nomenclature and severity scores for assessing disease activity.

Diagnostic and treatment-response accuracy — Dellon et al.

2016

Assessment of the EREFS for distinguishing eosinophilic oesophagitis from controls and for measuring response to treatment.

Confirmed that the score distinguishes patients with eosinophilic oesophagitis from controls and decreases with treatment, with histological responders scoring significantly lower than non-responders — supporting its use as a serial measure rather than a single-time-point one.

AGA and Joint Task Force clinical guidelines

2020

AGA Institute and Joint Task Force on Allergy-Immunology Practice Parameters clinical guidelines for the management of eosinophilic oesophagitis.

Set out the treatment framework — topical corticosteroids, proton pump inhibitors and dietary elimination — within which the inflammatory subscore is the component expected to respond.

Application across paediatric age groups

2020

Study applying the EREFS to children of different ages to assess whether the features and grading transfer to paediatric practice.

Supported use in children while highlighting that fibrostenotic features are less common in younger patients, so the inflammatory subscore carries proportionately more of the information in paediatric disease.

How it compares

EREFS (Eosinophilic Oesophagitis) vs Oesophageal biopsy and eosinophil count

Histology remains the diagnostic standard — EREFS describes appearance and cannot diagnose or exclude the disease.

Diagnosis rests on oesophageal eosinophilia, conventionally 15 or more eosinophils per high-power field, in the appropriate clinical context. EREFS correlates with activity and falls with treatment, but a normal-appearing oesophagus occurs in a meaningful minority of confirmed cases, so the score can never substitute for biopsies. In practice they are used together: histology for diagnosis and remission, EREFS for the structural picture that histology cannot show.

Dellon ES, Cotton CC, Gebhart JH, et al. Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment. Clin Gastroenterol Hepatol. 2016;14(1):31-39.

EREFS (Eosinophilic Oesophagitis) vs Los Angeles classification

Different diseases in the same organ — LA grades reflux erosions, EREFS grades the features of eosinophilic oesophagitis.

The two are frequently in the same differential, since both present with dysphagia and heartburn, and proton pump inhibitors treat both. They are not interchangeable: a mucosal break is not an EREFS feature, and furrows and rings are not LA findings. An endoscopy assessing dysphagia should record whichever applies, and take biopsies if eosinophilic oesophagitis is plausible.

Open the Los Angeles classification calculator →

EREFS (Eosinophilic Oesophagitis) vs Chicago Classification v4.0

Complementary — EREFS describes what the oesophagus looks like, Chicago describes how it moves, and dysphagia often needs both.

Eosinophilic oesophagitis can produce motility abnormalities, and a patient with dysphagia and a normal endoscopy may need manometry. Conversely a patient with rings on EREFS has a structural explanation that manometry will not add to. The two answer different halves of the dysphagia question.

Open the Chicago Classification v4.0 calculator →

Pearls & pitfalls

  • A normal-looking oesophagus does not exclude eosinophilic oesophagitis. A meaningful minority of confirmed cases score zero, which is why biopsies are mandatory whenever the diagnosis is considered.
  • Record both subscores, not just the total. Three patients with a total of 4 can face three different treatment decisions depending on composition.
  • Score the worst-affected segment for each feature, so maximal disease burden is captured rather than averaged out.
  • The original system grades furrows 0–1 for a maximum of 8. Some studies use 0–2, and some score proximal and distal segments separately up to 20 — always state which convention you are using.
  • Ring grades 2 and 3 are separated by whether a standard adult endoscope passes, not by how severe the rings look. Use the actual observation.
  • Fibrostenotic features may not improve with medical therapy. Residual dysphagia after the inflammatory subscore normalises is not necessarily treatment failure.
  • Take at least six biopsies from at least two oesophageal levels, targeting exudates and furrows where present — eosinophil density is patchy.
  • The score grades appearance only and does not replace histology, which remains the diagnostic standard and the measure of remission.
  • Repeat the score at follow-up. Its designed purpose is serial comparison, and a single value in isolation wastes most of its information.

Critical actions

  • Take oesophageal biopsies at every endoscopy where eosinophilic oesophagitis is considered, regardless of the EREFS — including when it is zero.
  • Record the inflammatory and fibrostenotic subscores separately in the endoscopy report.
  • Where a stricture or grade 3 rings are present, consider dilation alongside anti-inflammatory therapy rather than instead of it.
  • Repeat endoscopy with scoring after a treatment trial, and judge response on the inflammatory subscore and histology together.
  • Before escalating anti-inflammatory treatment for a fibrostenotic-only pattern, confirm there is histological activity to treat.
  • State which grading convention was used, since the furrows scale and segment reporting vary between studies.
  • Assess for food impaction risk and counsel accordingly where rings or stricture are present.

Why this score exists

The paper's stated aim was interobserver agreement, not severity measurement, and that ordering explains the design. Before EREFS the literature contained at least four names for the same ring finding, which meant studies could not be pooled and a patient's endoscopy report could not be compared with the one from two years earlier. Fixing the vocabulary came first; grading was added only where a gradation could be judged consistently, which is why oedema, furrows and stricture stayed binary while rings earned four levels. The choice to anchor ring severity to whether a standard adult endoscope passes is the sharpest example of that discipline — it replaces a subjective impression of narrowing with something the endoscopist directly observes while doing the procedure anyway. The inflammatory and fibrostenotic split then fell out naturally, and turned out to carry more clinical information than the total it was derived from.

About the creator

  • Ikuo Hirano

    First author, 2013 validation study

    Led the development and validation of the EREFS classification and grading system, and co-authored the AGA/JTF management guidelines.

  • Nirmala Gonsalves

    Co-author of the 2013 validation study.

  • Sami R. Achem

    Co-author of the 2013 validation study.

Limitations

  • Grades endoscopic appearance only and cannot diagnose or exclude eosinophilic oesophagitis, since a meaningful minority of confirmed cases have a normal-appearing oesophagus.
  • Grading conventions vary between studies — furrows scored 0–1 or 0–2, and single-segment or proximal-plus-distal totals — so scores from different sources are not directly comparable.
  • Interobserver agreement, while good for the major features, was established among gastroenterologists reviewing selected videos rather than in unselected routine practice.
  • Oedema depends on the visibility of vascular markings, which is affected by insufflation, light source and image processing as much as by disease.
  • The fibrostenotic subscore is coarse: rings and stricture between them offer only five possible values, which limits sensitivity to change in remodelling.
  • Does not capture crepe-paper mucosa or narrow-calibre oesophagus, both of which carry practical importance for dilation risk.
  • Fibrostenotic features are uncommon in young children, so the score carries less information in paediatric disease.

If you are the patient

Eosinophilic oesophagitis is an allergic condition in which the gullet becomes inflamed, causing food to stick or difficulty swallowing. At endoscopy the doctor looks for five particular changes — swelling of the lining, ring-like ridges, white patches, vertical lines, and narrowing — and scores each one. Adding them up gives the EREFS, out of 8. The useful part is that these five split into two groups. Three of them reflect active inflammation, and these are the ones that usually improve with treatment such as steroid medicines that coat the gullet, acid-reducing tablets, or removing certain foods from the diet. The other two — rings and narrowing — reflect scarring that has built up over time, and these often do not improve with medicines; a stretching procedure may be needed instead. That distinction explains why swallowing can still be difficult after treatment has successfully calmed the inflammation. One important point: even when the gullet looks completely normal, small tissue samples are still taken, because a normal appearance does not rule the condition out.

Frequently asked questions

What is the EREFS?#

The Eosinophilic Oesophagitis Endoscopic Reference Score: oedema (0–1), rings (0–3), exudates (0–2), furrows (0–1) and stricture (0–1), summed to a maximum of 8 on the worst-affected segment.

What is the difference between the inflammatory and fibrostenotic subscores?#

The inflammatory subscore is oedema plus exudates plus furrows (maximum 4) and reflects active inflammation that responds to medical therapy. The fibrostenotic subscore is rings plus stricture (maximum 4) and reflects established remodelling, which often requires dilation instead. The same total can mean very different things depending on the split.

Does an EREFS of zero exclude eosinophilic oesophagitis?#

No. A meaningful minority of patients with histologically confirmed disease have a completely normal-appearing oesophagus. Biopsies are mandatory whenever the diagnosis is considered, regardless of the score.

Is the maximum score 8 or 20?#

The original system grades furrows 0–1 and gives a maximum of 8 for a single segment, which is what this calculator uses. Some later studies grade furrows 0–2, and some report proximal and distal segments separately for a total up to 20 — so always state which convention a score was recorded under.

How are ring severity grades distinguished?#

By whether a standard adult endoscope passes. Grade 1 is subtle circumferential ridges, grade 2 is distinct rings that the endoscope passes, and grade 3 is distinct rings that it does not. Anchoring to endoscope passage rather than appearance is what makes grades 2 and 3 reproducible.

Why is dysphagia sometimes unchanged after successful treatment?#

Because the inflammatory features may have resolved while the fibrostenotic ones have not. Rings and stricture reflect remodelling that anti-inflammatory therapy often does not reverse, so residual dysphagia with a normalised inflammatory subscore is not necessarily treatment failure — it may be an indication for dilation.

How many biopsies should be taken?#

At least six, from at least two oesophageal levels, targeting areas with exudates or furrows where present. Eosinophil density is patchy, so a small number of biopsies from one level risks a false-negative result.

Should the EREFS be repeated?#

Yes. It was designed for serial use, and most of its value lies in the change between endoscopies rather than in any single value. Record it even when the oesophagus looks normal, so that a later score has a baseline to be read against.

Related calculators

  • LA Classification (Oesophagitis) — Los Angeles grade A–D for erosive oesophagitis
  • Prague C & M Criteria — Circumferential and maximal extent of Barrett's oesophagus
  • Chicago Classification v4.0 — Oesophageal motility pattern from high-resolution manometry
  • Functional Dysphagia — Rome IV — dysphagia with normal endoscopy and manometry
  • Globus — Rome IV — painless lump-in-throat sensation
  • Functional Heartburn — Rome IV — heartburn with normal acid exposure

References

Original / primary reference

  1. Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62(4):489-495.

Validation and guidelines

  1. Dellon ES, Cotton CC, Gebhart JH, et al. Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment. Clin Gastroenterol Hepatol. 2016;14(1):31-39.
  2. Hirano I, Chan ES, Rank MA, et al. AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis. Gastroenterology. 2020;158(6):1776-1786.

Last updated August 1, 2026. Clinical knowledge base written and curated by GastroAGI Team from primary medical literature.

Written from primary literature and not yet independently clinically reviewed.

For use by qualified healthcare professionals. This calculator supports clinical judgement and does not replace it.